Jim Lee

Jim Lee

Company: Incyte

Job title: Group Vice President, Head of Inflammation and Autoimmunity

Seminars:

Speaker Q&A panel 11:00 am

Read more

day: Day Two

Targeting JAK Signalling in the Treatment of Vitiligo 10:35 am

Overview of vitiligo pathogenesis, psychosocial comorbidities and unmet medical need Discuss vitiligo competitive landscape, current challenges in conducting vitiligo clinical trials and regulatory path Demonstrate efficacy and safety of ruxolitinib (JAK inhibitor) cream and discuss subgroup analysis based on patient demographics and clinical characteristics from a phase 2 vitiligo clinical trialRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.